Cargando…
Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
3CL protease is one of the key proteins expressed by SARS-Coronavirus-2 cell, the potential to be targeted in the discovery of antivirus during this COVID-19 pandemic. This protein regulates the proteolysis of viral polypeptide essential in forming RNA virus. 3CL protease (3CLpro) was commonly targe...
Autores principales: | Hartini, Yustina, Saputra, Bakti, Wahono, Bryan, Auw, Zerlinda, Indayani, Friska, Adelya, Lintang, Namba, Gabriel, Hariono, Maywan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832947/ https://www.ncbi.nlm.nih.gov/pubmed/33520632 http://dx.doi.org/10.1016/j.rechem.2020.100087 |
Ejemplares similares
-
The Future of Carica papaya Leaf Extract as an Herbal Medicine Product
por: Hariono, Maywan, et al.
Publicado: (2021) -
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
por: Mody, Vicky, et al.
Publicado: (2021) -
Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2
por: Ferreira, Juliana C., et al.
Publicado: (2020) -
GC-MS, LC-MS/MS, Docking and Molecular Dynamics Approaches to Identify Potential SARS-CoV-2 3-Chymotrypsin-Like Protease Inhibitors from Zingiber officinale Roscoe
por: Zubair, Muhammad Sulaiman, et al.
Publicado: (2021) -
Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies
por: Hariono, Maywan, et al.
Publicado: (2021)